Description

The evidence base and research agenda for malaria elimination and eradication are fast-evolving. Of foremost concern is the threat of resistance of the mosquito to pyrethroid insecticides and emerging data showing multi-drug resistance in Southeast Asia. An evolving area, with much to be understood, is the epidemiology of sub-microscopic infections and how they fuel onward transmission. There is also a lot of progress; for example, in the development pipeline there are candidates for a single-dose cure that can also provide protection and block transmission, and there are novel classes of insecticides. In implementation science, there is plenty to examine, from mass drug administration of anti-malarials to re-purposing ivermectin to reduce residual transmission.

Watch this lively panel discussion moderated by Prof Marcel Tanner examining the scientific progress being made toward the goals of eliminating and eradicating malaria, and then ask the panelists your own questions.

Among other topics, the discussion will focus on:

Biological challenges and discoveriesDevelopment of the next generation of toolsPotentially transformative strategies to eliminate malariaThe impact of training and capacity building on malaria elimination goalsSurveillance-response approaches in malaria elimination

Event Hashtag: #VKSmalaria



This event is a collaboration with:

Moderator(s):

• Marcel Tanner, PhD, MPH, Swiss Tropical and Public Health Institute

Panelist(s):

• Salim Abdulla, MSc, PhD, Ifakara Health Institute
• Marcus Lacerda, MD, PhD, Sociedade Brasileira de Medicina Tropical 
• Jetsumon Prachumsri, PhD, Mahidol University
• Sarah K. Volkman, ScD, Harvard T.H. Chan School of Public Health
• Silvie Huijben, PhD, Barcelona Institute of Global Health (ISGlobal)
• Gawrie L. Galappaththy, MBBS,MD, MSc, World Health Organization - Global Malaria Programme
• Elizabeth C. Kawesha, MD, Ministry of Health, Zambia
• Vladimir Corredor, PhD, Universidad Nacional de Colombia